J Transl Med
AdiponectinBlood ProteinsDiabetes Mellitus, Type 2
Mark Dinubile
NPI1487069167
- Publications
- 56
- Industry payments
- $28
- State license
- 1
- Year NPI issued
- 2014
- Practice address
- 505 Bartram Rd, Moorestown-Lenola, NJ 08057-1833
- Practice phone
- Call (609) 706-5866
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Mark Dinubile's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Mark Dinubile is an infectious disease specialist in Moorestown-Lenola, New Jersey
Mark Dinubile practices in Moorestown-Lenola, New Jersey.
Mark Dinubile's NPI, 1487069167, was assigned on June 21, 2014. Mark Dinubile holds New Jersey license 25MA05030600.
NPI and contact details
- NPI
- 1487069167NPI Registry (opens in a new tab)
- NPI enumeration date
- June 21, 2014
- NPI status
- Active
- Practice phone
- (609) 706-5866
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Mark Dinubile's practice address is in Moorestown-Lenola, New Jersey
Mark Dinubile's practice address in the NPI Registry is 505 Bartram Rd, Moorestown-Lenola, NJ 08057-1833. The practice phone is (609) 706-5866.
- NPI Registry address505 Bartram Rd, Moorestown-Lenola, NJ 08057-1833Phone(609) 706-5866
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Mark Dinubile's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Mark Dinubile practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Mark Dinubile's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Mark Dinubile practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Mark Dinubile is one of 340 infectious disease specialists in New Jersey
Infectious disease is Mark Dinubile's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Mark Dinubile is licensed in New Jersey.
Specialties and state licenses
- Infectious disease, New JerseyPrimary
Infectious disease specialists near Mark Dinubile
Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Mark Dinubile has 56 publications on record
Dmand AI links 56 papers to Mark Dinubile, published from 2002 to 2023. 2014 was the busiest year, with 5. The most frequent topics are Double-Blind Method, Genotype and Drug Therapy, Combination. Mark Dinubile has published most often in Open Forum Infect Dis. Mark Dinubile's most frequent co-authors are Randi Leavitt, MD, Christopher R. Gilbert, DO and Alfred Joseph Saah, MD.
Papers56
Years published2002 to 2023
Mark Dinubile's papers by year, 2014 to 2023
Topics Mark Dinubile writes about most
- Double-Blind Method
- Genotype
- Drug Therapy, Combination
- Gelsolin
- Anti-Bacterial Agents
- Antiviral Agents
- Ribavirin
- Cyclopropanes
Mark Dinubile's most frequent co-authors
- Randi Leavitt, MD6 shared papers
- Christopher R. Gilbert, DO3 shared papers
- Alfred Joseph Saah, MD3 shared papers
Recent publications by Mark Dinubile
Aging Clin Exp Res
Frail ElderlyFrailtyGelsolin
See who Mark Dinubile researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Mark Dinubile works with, so you can find a warm path to the right infectious disease specialists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Mark Dinubile received $28 in industry payments in 2016
CMS Open Payments shows 1 general payment to Mark Dinubile from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $28.
Companies that paid Mark Dinubile the most, 2016 to 2016
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Mark Dinubile's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Mark Dinubile
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Mark Dinubile's NPI number?
Mark Dinubile's NPI number is 1487069167. It was assigned on June 21, 2014, and it is active in the NPI Registry.
What does Mark Dinubile specialize in?
Mark Dinubile is an infectious disease specialist in Moorestown-Lenola, New Jersey. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).
Where does Mark Dinubile practice?
Mark Dinubile practices at 505 Bartram Rd, Moorestown-Lenola, NJ 08057-1833.
What is Mark Dinubile's office phone number?
The practice phone on file for Mark Dinubile is (609) 706-5866.
What is Mark Dinubile's medical license number?
Mark Dinubile holds New Jersey license 25MA05030600.
Has Mark Dinubile received payments from drug or device companies?
CMS Open Payments shows $28 in general payments to Mark Dinubile from 1 company from 2016 to 2016. The largest total came from Pfizer Inc.
How long has Mark Dinubile been practicing?
Mark Dinubile's NPI was assigned in 2014.
Does Mark Dinubile do research?
Dmand AI links 56 publications to Mark Dinubile, published from 2002 to 2023.
Who does Mark Dinubile publish with?
Mark Dinubile's most frequent co-authors are Randi Leavitt, MD (6 shared papers), Christopher R. Gilbert, DO (3 shared papers) and Alfred Joseph Saah, MD (3 shared papers).
Selling to infectious disease practices?
See infectious disease specialists in New Jersey by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card